The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Biocomposites sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Biocomposites Ltd (Biocomposites) is a medical device company that develops and manufactures calcium compound devices designed to regenerate and repair bone and soft tissue. The company’s activities include the innovation and production of these devices, with a focus on addressing musculoskeletal infections, trauma, spine and sports injuries. Biocomposites offers a range of products including STIMULAN, SYNICEM Spacers, genex, NanoBone, Biosteon, Allogran-R, Subiton Cements and Bilok. Its products are used by surgeons and healthcare professionals in various clinical applications to help patients with bone and joint trauma, musculoskeletal infections and spine surgeries. The company also provides educational resources for distributor representatives to meet their surgeons’ needs. It operates in the UK, the US, China, India, Germany and Argentina. Biocomposites is headquartered in Keele, Staffordshire, England, the UK. Key subsidiaries of Biocomposites include ARTOSS and Biocomposites Shanghai.
The key metrics of Biocomposites related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Biocomposites is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Biocomposites.
For a detailed understanding of the performance of Biocomposites, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
